Here are five observations:
1. The growing adoption of viscosupplementation products, bone marrow concentrate and specific growth factors are also key market drivers.
2. Within the market, the autograft segment dominates due to their compatibility and reduced side effects.
3. Platelet rich plasma is gaining popularity in the sports medicine market.
4. North America and Europe lead the space, with the Asia-Pacific region and Latin America set for significant growth.
5. Key market players include Stryker, Arthrex, Isto Biologics, Anika Therapeutics, RTI Surgical, DePuy Synthes, Lattice Biologics, SeaSpine and Citagenix.
More articles on devices:
DePuy Synthes receives up to $260M US Department of Defense contract: 5 key notes
Mazor, Xtant Medical, InVivo Therapeutics & more: 18 device company key notes
Histogenics receives innovation award
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
